期刊文献+

糖皮质激素性骨质疏松防治进展 被引量:2

暂未订购
导出
摘要 糖皮质激素由于其强大的抗炎及免疫抑制作用,在多种疾病的诊断和治疗上得以广泛应用,其在风湿性疾病中的应用更为普遍。糖皮质激素诱导的骨质疏松(GIOP)是长期应用激素的主要副作用之一,也是继发性骨质疏松的最主要原因。因此,近年来受到临床医生的重视。
作者 连莉 徐建华
出处 《临床内科杂志》 CAS 2011年第10期653-655,共3页 Journal of Clinical Internal Medicine
  • 相关文献

参考文献18

  • 1Popp AW, Isenegger J, Buergi EM, et al. Glucocorticosteroid-induced spinal osteoporosis:scientific update on pathophysiology and treatment. Eur Spine J ,2006,15 : 1035-1049.
  • 2Mazziotti G, Canalis E, Giustina A. Drug-induce osteoporosis: mechanisms and clinical implications. Am J Med,2010,123:877-884.
  • 3AL-Osail AM, Sadat-Mi M, AL-Elq AH. Glucocorticoid-related osteoporotic fractures. Singapore Med J ,2010,51:948-951.
  • 4Dliuc D, Nguven ND, Milch IE, et al. Mortality risk associated with lowtrauma osteoporotie fracture and subsequent fracture in men and women. JAMA ,2009,301:513-521.
  • 5Ohnaka K, Tanabe M, Kawate H, et al. Glucocortlcoid suppresses the canonical Wnt signal in cultured human osteoblasts. Biochem Biophys Res Commun ,2005 ,329 : 177-181.
  • 6Hong D, Chen HX, Yu HQ, et al. Quantitative proteomic analysis of dexamethasone-induced effects on osteoblast differentiation, proliferation,and apoptosis in MC3T3-EI cells using SLIAC. Osteoporos Int, 2011,22:2175-2186.
  • 7Deal C. Potential new drug targets for osteoporosis. Nat Clin Pract Rheumatol, 2009,5 : 20-27.
  • 8Van Staa TP, Geusens P, Pols HA, et al. A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. QJM ,2005,98 : 191-198.
  • 9Maruotti N, Corrado A, Cantatore FP. Glucocorticoid induced risk of fractures. Panminerv a Med, 2010,52 : 339 -343.
  • 10Frediani B, Falsetti P, Bisogno S, et al. Effects of high dose methylprednisolone pulse therapy on bone mass and biochemical markers of bone metabolism in patients with active rheumatoid arthritis: a 12-month randomized prospective controlled study. J Rheumatol, 2004, 31 : 1083-1087.

共引文献1876

同被引文献36

  • 1苏欣,廖二元,彭健,伍贤平.雌二醇对人成骨肉瘤MG63细胞株护骨素、护骨素配体及其相关因子的调节[J].中华内科杂志,2003,42(11):800-803. 被引量:13
  • 2叶凡,吴小涛.糖皮质激素性骨质疏松症的发病机制研究进展[J].东南大学学报(医学版),2005,24(3):210-212. 被引量:21
  • 3梁九根,蒋宁一,徐志英,卢献平,刘幸光,陈少雄.长期强的松治疗对绝经前SLE患者骨密度的影响[J].中国骨质疏松杂志,2006,12(1):57-58. 被引量:5
  • 4李夏玉,范永升.系统性红斑狼疮的中医药治疗近况[J].中国中医急诊,2011,20(16):942-943.
  • 5Hahn TJ,Hahn BH.Osteopenia in patients with rheumatic dis-ease:principles of diagnosis and therapy[J].Semin Arthritis Re-hum,1976,6(2):165-188.
  • 6Cunnane G,Lane NE.Steroid-induced osteoporosis in systemic lu-pus erythematosus[J].Rheum Dis Clin North Am,2000,26(2):311-329.
  • 7Suzuki Y,Sato S.Secondary osteoporosis UPDATE.Clinical signif-icance glucocorticoid-induced osteoporosis[J].Clin Calcium,2010,20(5):645-653.
  • 8Redlich K,Zieler S,Kiener HP,et al.Bone mineral density and bi-ochemical parameters of bone metabolism in female patients withsystemic lupus erythematosus[J].Ann Rheum Dis,2000,59(4):308-310.
  • 9Lee C,Goldman R.Osteopemsis in systemic lupus erythematosusmechanisms[J].Rheum Dis Clin North Am,2005,31(2):363-385.
  • 10Weinstein RS,Nicholas RW,Manolagas SC.Apoptosis of osteocyteglucocorticoid-induced osteonecrosis of the hip[J].Clin Endocri-nolMetab,2004,85(8):2907-2912.

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部